Search research articles
Contact Us
Filters
Showing results (351-360 of 379) with videos related to
Page
of 38
Sort By:
European Journal of Medicinal Chemistry
|
July 15, 2018
A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway
Shuangwei Liu, Xian Gao, Lisong Zhang, et al.
ACS Infectious Diseases
|
September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>
John M Bennett, Kurt E Ward, Ryan K Muir, et al.
Biorxiv : the Preprint Server for Biology
|
August 20, 2025
Recombinant proteasome provides new avenues for anti-malarial drug development
Pavla Fajtova, Hanxiao Zhang, Liam Urich, et al.
Cell Host & Microbe
|
March 11, 2008
Selective killing of nonreplicating mycobacteria
Ruslana Bryk, Benjamin Gold, Aditya Venugopal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 16, 2009
Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice
Xiao-dong Peng, Xiao-hua Wu, Li-juan Chen, et al.
Journal of Medicinal Chemistry
|
September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> Proteasome
Wenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Journal of the National Cancer Institute
|
December 7, 2006
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy
Peggy L Porter, William E Barlow, I-Tien Yeh, et al.
International Journal of Cancer
|
February 22, 2005
Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China
Wenjin Li, Roberta M Ray, Johanna W Lampe, et al.
American Journal of Epidemiology
|
November 4, 2004
A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000
Chunyuan Wu, Roberta M Ray, Ming Gang Lin, et al.
European Journal of Medicinal Chemistry
|
July 18, 2020
Design and synthesis of Leukotriene A4 hydrolase inhibitors to alleviate idiopathic pulmonary fibrosis and acute lung injury
Xiaohe Li, Maodun Xie, Cheng Lu, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 379) with videos related to
Sort By:
Page
of 38
European Journal of Medicinal Chemistry
|
July 15, 2018
A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway
Shuangwei Liu, Xian Gao, Lisong Zhang, et al.
ACS Infectious Diseases
|
September 15, 2023
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in <i>Plasmodium falciparum</i>
John M Bennett, Kurt E Ward, Ryan K Muir, et al.
Biorxiv : the Preprint Server for Biology
|
August 20, 2025
Recombinant proteasome provides new avenues for anti-malarial drug development
Pavla Fajtova, Hanxiao Zhang, Liam Urich, et al.
Cell Host & Microbe
|
March 11, 2008
Selective killing of nonreplicating mycobacteria
Ruslana Bryk, Benjamin Gold, Aditya Venugopal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 16, 2009
Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice
Xiao-dong Peng, Xiao-hua Wu, Li-juan Chen, et al.
Journal of Medicinal Chemistry
|
September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> Proteasome
Wenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Journal of the National Cancer Institute
|
December 7, 2006
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy
Peggy L Porter, William E Barlow, I-Tien Yeh, et al.
International Journal of Cancer
|
February 22, 2005
Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China
Wenjin Li, Roberta M Ray, Johanna W Lampe, et al.
American Journal of Epidemiology
|
November 4, 2004
A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000
Chunyuan Wu, Roberta M Ray, Ming Gang Lin, et al.
European Journal of Medicinal Chemistry
|
July 18, 2020
Design and synthesis of Leukotriene A4 hydrolase inhibitors to alleviate idiopathic pulmonary fibrosis and acute lung injury
Xiaohe Li, Maodun Xie, Cheng Lu, et al.
Page
of 38